- Home
- XENE vs GHC Comparison
XENE vs GHC Comparison
Compare XENE & GHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- GHC
- Stock Information
- Founded
- XENE 1996
- GHC 1877
- Country
- XENE Canada
- GHC United States
- Employees
- XENE N/A
- GHC N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- GHC Other Consumer Services
- Sector
- XENE Health Care
- GHC Real Estate
- Exchange
- XENE Nasdaq
- GHC Nasdaq
- Market Cap
- XENE 3.0B
- GHC 3.5B
- IPO Year
- XENE 2014
- GHC N/A
- Fundamental
- Price
- XENE $42.23
- GHC $939.77
- Analyst Decision
- XENE Strong Buy
- GHC
- Analyst Count
- XENE 10
- GHC 0
- Target Price
- XENE $57.30
- GHC N/A
- AVG Volume (30 Days)
- XENE 367.1K
- GHC 13.4K
- Earning Date
- XENE 11-12-2024
- GHC 10-30-2024
- Dividend Yield
- XENE N/A
- GHC 0.74%
- EPS Growth
- XENE N/A
- GHC 53.73
- EPS
- XENE N/A
- GHC 51.18
- Revenue
- XENE N/A
- GHC $4,711,917,000.00
- Revenue This Year
- XENE N/A
- GHC $10.51
- Revenue Next Year
- XENE $1,600.08
- GHC $2.71
- P/E Ratio
- XENE N/A
- GHC $18.28
- Revenue Growth
- XENE N/A
- GHC 9.27
- 52 Week Low
- XENE $28.10
- GHC $613.39
- 52 Week High
- XENE $50.99
- GHC $972.13
- Technical
- Relative Strength Index (RSI)
- XENE 48.00
- GHC 68.80
- Support Level
- XENE $41.42
- GHC $825.15
- Resistance Level
- XENE $44.61
- GHC $972.13
- Average True Range (ATR)
- XENE 1.40
- GHC 18.64
- MACD
- XENE -0.15
- GHC 12.79
- Stochastic Oscillator
- XENE 25.94
- GHC 86.10
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.
About GHC Graham Holdings Company
Graham Holdings Co. is a diversified education and media company made up of subsidiaries. Firm operations include educational services; television broadcasting; online, print, and local news; home health and hospice care; and manufacturing. The Company segments into the following seven reportable segments: Kaplan International, Higher Education, Supplemental Education, Television Broadcasting, Manufacturing, Healthcare, and Automotive. The majority of revenue comes from the Kaplan International segment, which includes higher education, test preparation, language instruction, and professional training. A large portion of company revenue also comes from the television broadcasting segment through advertising.